1. Home
  2. BMRN vs SNX Comparison

BMRN vs SNX Comparison

Compare BMRN & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • SNX
  • Stock Information
  • Founded
  • BMRN 1996
  • SNX 1980
  • Country
  • BMRN United States
  • SNX United States
  • Employees
  • BMRN N/A
  • SNX N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • SNX Retail: Computer Software & Peripheral Equipment
  • Sector
  • BMRN Health Care
  • SNX Technology
  • Exchange
  • BMRN Nasdaq
  • SNX Nasdaq
  • Market Cap
  • BMRN 9.9B
  • SNX 13.3B
  • IPO Year
  • BMRN 1999
  • SNX 2003
  • Fundamental
  • Price
  • BMRN $54.93
  • SNX $150.92
  • Analyst Decision
  • BMRN Buy
  • SNX Strong Buy
  • Analyst Count
  • BMRN 19
  • SNX 10
  • Target Price
  • BMRN $90.26
  • SNX $169.00
  • AVG Volume (30 Days)
  • BMRN 2.8M
  • SNX 527.5K
  • Earning Date
  • BMRN 10-27-2025
  • SNX 09-25-2025
  • Dividend Yield
  • BMRN N/A
  • SNX 1.17%
  • EPS Growth
  • BMRN 59.53
  • SNX 18.98
  • EPS
  • BMRN 2.68
  • SNX 9.21
  • Revenue
  • BMRN $3,094,001,000.00
  • SNX $60,973,509,000.00
  • Revenue This Year
  • BMRN $13.32
  • SNX $7.25
  • Revenue Next Year
  • BMRN $7.51
  • SNX $4.50
  • P/E Ratio
  • BMRN $20.23
  • SNX $16.34
  • Revenue Growth
  • BMRN 12.39
  • SNX 6.94
  • 52 Week Low
  • BMRN $50.76
  • SNX $92.23
  • 52 Week High
  • BMRN $73.51
  • SNX $167.76
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 56.09
  • SNX 46.05
  • Support Level
  • BMRN $50.76
  • SNX $149.37
  • Resistance Level
  • BMRN $55.34
  • SNX $154.81
  • Average True Range (ATR)
  • BMRN 1.76
  • SNX 3.63
  • MACD
  • BMRN 0.34
  • SNX -0.31
  • Stochastic Oscillator
  • BMRN 69.54
  • SNX 26.06

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

Share on Social Networks: